A key challenge for regulators including the HRA, and maybe the health care Group in general, is to find out when and the way to re-study long standing viewpoints or dogmas. Exactly when should anecdotal evidence from sometimes extremely vocal affected individual teams be tested in time consuming and costly medical trials?Get started with sterilize